Three Dimensional Conformal versus Volumetric Arc Therapy in Gynecological Cancer: A Retrospective Study Evaluating Therapeutic Effect and Toxicity.

IF 1.1 Q4 SURGERY
Chirurgia Pub Date : 2025-10-01 DOI:10.21614/chirurgia.3173
Ioanna Kantzou, Ioannis Georgakopoulos, Ioanna Markou, Georgios Vorgias, Angeliki Gerede, Eleni Bekou, Francesk Mulita, Elias Liolis, Christos Iavazzo, Sofia Ioannidou, Athina Markouizou, Georgios Sarris, Vasileios Kouloulias, Anna Zygogianni
{"title":"Three Dimensional Conformal versus Volumetric Arc Therapy in Gynecological Cancer: A Retrospective Study Evaluating Therapeutic Effect and Toxicity.","authors":"Ioanna Kantzou, Ioannis Georgakopoulos, Ioanna Markou, Georgios Vorgias, Angeliki Gerede, Eleni Bekou, Francesk Mulita, Elias Liolis, Christos Iavazzo, Sofia Ioannidou, Athina Markouizou, Georgios Sarris, Vasileios Kouloulias, Anna Zygogianni","doi":"10.21614/chirurgia.3173","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Technological advances in the field of radiation therapy have established modern techniques like Volumetric Modulated Arc Therapy (VMAT) as the radiation treatment of choice for nearly all malignancies. Unfortunately, due to many reasons that are not in the scope of this paper, even nowadays not all patients have access to these modern techniques and are managed with the \"older\" Three-Dimensional Conformal Radiation Therapy (3DCRT). \n<b>Methods:</b> In this retrospective study, we performed a comparison of VMAT to 3DCRT by terms of five (5) year overall survival (OS), disease-free survival (DFS), and toxicity in patients treated for endometrial and cervical cancer. A total of 173 gynecological cancer patients treated with either VMAT or 3D-CRT technique were included in this study: 73 patients (Group A) were treated with VMAT, and 100 patients (Group B) were managed with 3D-CRT technique. The endpoints of this trial were: disease free survival (DFS), overall survival (OS), and toxicity of treatment. \n<b>Results:</b> Our results showed significant 5-year DFS advantage for the patients in group A, while OS had no significant difference between the two groups. \n<b>Conclusion:</b> Reduced toxicity was demonstrated in group A compared to group B, regarding mostly gastrointestinal (GI) toxicity.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 5","pages":"538-545"},"PeriodicalIF":1.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chirurgia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21614/chirurgia.3173","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Technological advances in the field of radiation therapy have established modern techniques like Volumetric Modulated Arc Therapy (VMAT) as the radiation treatment of choice for nearly all malignancies. Unfortunately, due to many reasons that are not in the scope of this paper, even nowadays not all patients have access to these modern techniques and are managed with the "older" Three-Dimensional Conformal Radiation Therapy (3DCRT). Methods: In this retrospective study, we performed a comparison of VMAT to 3DCRT by terms of five (5) year overall survival (OS), disease-free survival (DFS), and toxicity in patients treated for endometrial and cervical cancer. A total of 173 gynecological cancer patients treated with either VMAT or 3D-CRT technique were included in this study: 73 patients (Group A) were treated with VMAT, and 100 patients (Group B) were managed with 3D-CRT technique. The endpoints of this trial were: disease free survival (DFS), overall survival (OS), and toxicity of treatment. Results: Our results showed significant 5-year DFS advantage for the patients in group A, while OS had no significant difference between the two groups. Conclusion: Reduced toxicity was demonstrated in group A compared to group B, regarding mostly gastrointestinal (GI) toxicity.

妇科肿瘤的三维适形与体积弧线治疗:疗效和毒性评价的回顾性研究。
导论:放射治疗领域的技术进步已经建立了现代技术,如体积调制电弧治疗(VMAT)作为几乎所有恶性肿瘤的放射治疗选择。不幸的是,由于许多不在本文范围内的原因,即使在今天,也不是所有的患者都能获得这些现代技术并使用â??olderâ?Â三维适形放疗(3DCRT)。方法:在这项回顾性研究中,我们对子宫内膜癌和宫颈癌患者的5年总生存期(OS)、无病生存期(DFS)和毒性进行了VMAT和3DCRT的比较。本研究共纳入173例采用VMAT或3D-CRT技术治疗的妇科肿瘤患者,其中VMAT组73例,B组100例,采用3D-CRT技术治疗。该试验的终点是:无病生存期(DFS)、总生存期(OS)和治疗毒性。结果:我们的研究结果显示,A组患者的5年DFS有显著优势,而两组患者的OS无显著差异。结论:与B组相比,A组毒性明显降低,主要是胃肠道毒性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Chirurgia
Chirurgia Medicine-Surgery
CiteScore
1.00
自引率
0.00%
发文量
75
审稿时长
4-8 weeks
期刊介绍: Chirurgia is a bimonthly journal. In Chirurgia, original papers in the area of general surgery which neither appeared, nor were sent for publication in other periodicals, can be published. You can send original articles, new surgical techniques, or comprehensive general reports on surgical topics, clinical case presentations and, depending on publication space, - reviews of some articles of general interest to surgeons from other publications. Chirurgia is also a place for sharing information about the activity of various branches of the Romanian Society of Surgery, information on Congresses and Symposiums organized by the Romanian Society of Surgery and participation notes in other scientific meetings. Letters to the editor: Letters commenting on papers published in Chirurgia are welcomed. They should contain substantive ideas and commentaries supported by appropriate data, and should not exceed 2 pages. Please submit these letters to the editor through our online system.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书